WARMINSTER, PA — Arbutus Biopharma Corporation recently announced a favorable outcome in its ongoing patent ... of the case, ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent ... and COVID-19 vaccines entered regular commercial trade with producers competing for the booster shot market ...
Shares in CureVac have plummeted after a German court ruled that a patent it holds ... coronavirus shot. CureVac – which is developing mRNA-based vaccines for COVID-19 and influenza with GSK ...
The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on ... after reviewing updated case data; Novavax said production ...
The Food and Drug Administration on Thursday approved new COVID shots manufactured by Pfizer-BioNTech and Moderna, as “currently circulating variants” continue to contribute to a surge in the ...
A healthcare provider gives a patient a Covid shot. The FDA approved new COVID-19 vaccines from Pfizer and Moderna on Thursday ... line after reviewing updated case data. Get Forbes Breaking ...
The Food and Drug Administration announced Thursday it has greenlighted updated COVID-19 vaccines from Pfizer and Moderna for the ... 6 months and older get a shot of the "updated 2024-2025 ...
Also Read: Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows. In early June ...
Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna stock tumbled again Friday on a series of downgrades and price-target cuts ...
It was her last chance at making an Olympic podium in Tokyo after she previously withdrew from five other individual event finals, and she had to adapt her routine to work around a case of the ...